Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Cash from Investing Activities (2016 - 2026)

Kewaunee Scientific (KEQU) has 16 years of Cash from Investing Activities data on record, last reported at -$1.6 million in Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 129.87% year-over-year to -$1.6 million; the TTM value through Oct 2025 reached -$32.3 million, down 1236.69%, while the annual FY2025 figure was -$30.9 million, 606.63% down from the prior year.
  • Cash from Investing Activities reached -$1.6 million in Q4 2025 per KEQU's latest filing, down from -$771000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$278000.0 in Q3 2024 and bottomed at -$29.4 million in Q1 2025.
  • Average Cash from Investing Activities over 5 years is -$2.2 million, with a median of -$647500.0 recorded in 2021.
  • Peak YoY movement for Cash from Investing Activities: skyrocketed 83.19% in 2024, then crashed 6094.53% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$446000.0 in 2021, then fell by 18.61% to -$529000.0 in 2022, then crashed by 139.13% to -$1.3 million in 2023, then surged by 46.01% to -$683000.0 in 2024, then plummeted by 129.87% to -$1.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$1.6 million in Q4 2025, -$771000.0 in Q3 2025, and -$516000.0 in Q2 2025.